Richard W. Compans
#92,492
Most Influential Person Now
Researcher
Richard W. Compans's AcademicInfluence.com Rankings
Richard W. Compansbiology Degrees
Biology
#4271
World Rank
#6393
Historical Rank
Microbiology
#142
World Rank
#168
Historical Rank
Download Badge
Biology
Why Is Richard W. Compans Influential?
(Suggest an Edit or Addition)Richard W. Compans's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Programming the magnitude and persistence of antibody responses with innate immunity (2010) (886)
- Characterization of temperature sensitive influenza virus mutants defective in neuraminidase. (1974) (808)
- Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus. (1998) (672)
- The three-dimensional structure of canine parvovirus and its functional implications. (1991) (484)
- Critical role for the chemokine receptor CXCR 6 in NK cell – mediated antigen-specific memory of haptens and viruses (2010) (447)
- Dissolving Polymer Microneedle Patches for Influenza Vaccination (2010) (446)
- Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection (2011) (404)
- Critical role for CXCR6 in NK cell-mediated antigen-specific memory to haptens and viruses (2010) (388)
- Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection (2011) (386)
- Influenza type A virus neuraminidase does not play a role in viral entry, replication, assembly, or budding (1995) (365)
- Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): mechanism of action. (1976) (355)
- Influenza virus proteins. I. Analysis of polypeptides of the virion and identification of spike glycoproteins. (1970) (332)
- Isolation of paramyxovirus glycoproteins. Association of both hemagglutinating and neuraminidase activities with the larger SV5 glycoprotein. (1972) (321)
- Influenza virus structural and nonstructural proteins in infected cells and their plasma membranes. (1971) (320)
- Virus-Like Particle Vaccine Induces Protective Immunity against Homologous and Heterologous Strains of Influenza Virus (2007) (315)
- Alpha/Beta Interferons Potentiate Virus-Induced Apoptosis through Activation of the FADD/Caspase-8 Death Signaling Pathway (2000) (310)
- Protection against vaginal SIV transmission with microencapsulated vaccine. (1993) (277)
- Reproduction of Paramyxoviruses (1975) (253)
- Structure of the Ribonucleoprotein of Influenza Virus (1972) (252)
- The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trial (2017) (246)
- Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity. (2010) (230)
- Functional interactions between the fusion protein and hemagglutinin-neuraminidase of human parainfluenza viruses (1992) (221)
- The M1 and M2 proteins of influenza A virus are important determinants in filamentous particle formation. (1998) (207)
- Original Antigenic Sin Responses to Influenza Viruses1 (2009) (198)
- Inhibition of influenza infection by glutathione. (2003) (194)
- Immunization by vaccine-coated microneedle arrays protects against lethal influenza virus challenge (2009) (190)
- An electron microscopic study of moderate and virulent virus-cell interactions of the parainfluenza virus SV5. (1966) (189)
- Human immunodeficiency virus envelope protein determines the site of virus release in polarized epithelial cells. (1991) (186)
- The membrane structure of lipid-containing viruses (1974) (176)
- Transdermal Influenza Immunization with Vaccine-Coated Microneedle Arrays (2009) (175)
- Influenza Virus-Like Particles Containing M2 Induce Broadly Cross Protective Immunity (2011) (173)
- Functional interaction of paramyxovirus glycoproteins: identification of a domain in Sendai virus HN which promotes cell fusion (1996) (167)
- Antigenic Subversion: A Novel Mechanism of Host Immune Evasion by Ebola Virus (2012) (160)
- Influenza vaccines based on virus-like particles. (2009) (152)
- Double-stranded RNA viruses (1983) (152)
- Respiratory syncytial virus matures at the apical surfaces of polarized epithelial cells (1995) (152)
- Induction of Heterosubtypic Immunity to Influenza Virus by Intranasal Immunization (2007) (148)
- Proteins and Glycoproteins of Paramyxoviruses: a Comparison of Simian Virus 5, Newcastle Disease Virus, and Sendai Virus (1971) (146)
- NAction! How Can Neuraminidase-Based Immunity Contribute to Better Influenza Virus Vaccines? (2018) (143)
- Incorporation of Membrane-Anchored Flagellin into Influenza Virus-Like Particles Enhances the Breadth of Immune Responses (2008) (137)
- Oral immunization with influenza virus in biodegradable microspheres. (1993) (136)
- Host cell dependence of viral morphology. (1998) (135)
- Proteins of Vesicular Stomatitis Virus and of Phenotypically Mixed Vesicular Stomatitis Virus-Simian Virus 5 Virions (1971) (135)
- Vaccination inducing broad and improved cross protection against multiple subtypes of influenza A virus (2010) (134)
- An electron microscopic study of single-cycle infection of chick embryo fibroblasts by influenza virus. (1969) (133)
- A specific labeling procedure for proteins on the outer surface of membranes. (1972) (132)
- Influenza virus proteins. II. Association with components of the cytoplasm. (1973) (131)
- Cytoplasmic domain truncation enhances fusion activity by the exterior glycoprotein complex of human immunodeficiency virus type 2 in selected cell types (1992) (130)
- Effects of glucosamine, 2-deoxyglucose, and tunicamycin on glycosylation, sulfation, and assembly of influenza viral proteins. (1978) (130)
- Peptides corresponding to the heptad repeat sequence of human parainfluenza virus fusion protein are potent inhibitors of virus infection. (1996) (130)
- Proteolytic cleavage of the hemagglutinin polypeptide of influenza virus. Function of the uncleaved polypeptide HA. (1973) (128)
- Influenza virus hemagglutinin expression is polarized in cells infected with recombinant SV40 viruses carrying cloned hemagglutinin DNA (1983) (124)
- Intradermal Vaccination with Influenza Virus-Like Particles by Using Microneedles Induces Protection Superior to That with Intramuscular Immunization (2010) (122)
- Cell fusion activity of the simian immunodeficiency virus envelope protein is modulated by the intracytoplasmic domain. (1993) (121)
- Double-layered protein nanoparticles induce broad protection against divergent influenza A viruses (2018) (120)
- Nucleocapsid Protein Subunits of Simian Virus 5, Newcastle Disease Virus, and Sendai Virus (1970) (119)
- Improved influenza vaccination in the skin using vaccine coated microneedles. (2009) (117)
- Enhanced memory responses to seasonal H1N1 influenza vaccination of the skin with the use of vaccine-coated microneedles. (2010) (116)
- Association of the parainfluenza virus fusion and hemagglutinin-neuraminidase glycoproteins on cell surfaces (1997) (116)
- Viruslike particle vaccine induces protection against respiratory syncytial virus infection in mice. (2011) (116)
- Induction of Long-Term Protective Immune Responses by Influenza H5N1 Virus-Like Particles (2009) (115)
- Roles of Host Gene and Non-coding RNA Expression in Virus Infection (2018) (114)
- An infectious clone of the West Nile flavivirus. (2001) (114)
- Immunity to Pre-1950 H1N1 Influenza Viruses Confers Cross-Protection against the Pandemic Swine-Origin 2009 A (H1N1) Influenza Virus (2010) (112)
- Stability of influenza vaccine coated onto microneedles. (2012) (109)
- Polarity of influenza and vesicular stomatitis virus maturation in MDCK cells: lack of a requirement for glycosylation of viral glycoproteins. (1979) (107)
- Truncation of the cytoplasmic domain of the simian immunodeficiency virus envelope glycoprotein alters the conformation of the external domain (1994) (107)
- Phenotypic Mixing of Envelope Proteins of the Parainfluenza Virus SV5 and Vesicular Stomatitis Virus (1970) (105)
- Ebola virus-like particles produced in insect cells exhibit dendritic cell stimulating activity and induce neutralizing antibodies. (2006) (105)
- Nontemplated bases at the 5' ends of Tacaribe virus mRNAs. (1990) (104)
- Virus-like Particles Containing Multiple M2 Extracellular Domains Confer Improved Cross-protection Against Various Subtypes of Influenza Virus. (2013) (103)
- Influenza virus inhibits ENaC and lung fluid clearance. (2004) (103)
- Membrane interactions of synthetic peptides corresponding to amphipathic helical segments of the human immunodeficiency virus type-1 envelope glycoprotein. (1992) (103)
- Dose sparing enabled by skin immunization with influenza virus-like particle vaccine using microneedles. (2010) (103)
- Enhanced Immunogenicity of Stabilized Trimeric Soluble Influenza Hemagglutinin (2010) (103)
- Polarized entry and release in epithelial cells of Black Creek Canal virus, a New World hantavirus (1997) (102)
- Delivery of subunit influenza vaccine to skin with microneedles improves immunogenicity and long-lived protection (2012) (101)
- Oligomerization of the hydrophobic heptad repeat of gp41 (1995) (101)
- Enhanced Mucosal Immune Responses to HIV Virus-Like Particles Containing a Membrane-Anchored Adjuvant (2011) (100)
- Apolipoprotein A-I and its amphipathic helix peptide analogues inhibit human immunodeficiency virus-induced syncytium formation. (1990) (100)
- Assembly of SIV virus-like particles containing envelope proteins using a baculovirus expression system. (1995) (99)
- Virus Infection of Polarized Epithelial Cells (1993) (99)
- Salmonella flagellins are potent adjuvants for intranasally administered whole inactivated influenza vaccine. (2010) (99)
- Stabilization of Influenza Vaccine Enhances Protection by Microneedle Delivery in the Mouse Skin (2009) (98)
- Virus-Like Particle Vaccine Protects against 2009 H1N1 Pandemic Influenza Virus in Mice (2010) (98)
- Transcutaneous immunization with inactivated influenza virus induces protective immune responses. (2006) (95)
- The P gene of human parainfluenza virus type 1 encodes P and C proteins but not a cysteine-rich V protein (1991) (95)
- Role of Actin Microfilaments in Black Creek Canal Virus Morphogenesis (1998) (95)
- Surface expression of viral glycoproteins is polarized in epithelial cells infected with recombinant vaccinia viral vectors. (1986) (94)
- The human and simian immunodeficiency virus envelope glycoprotein transmembrane subunits are palmitoylated. (1995) (94)
- Release of simian virus 40 virions from epithelial cells is polarized and occurs without cell lysis (1989) (94)
- Murine model for evaluation of protective immunity to influenza virus. (1993) (94)
- Effects of antibody to the influenza A virus M2 protein on M2 surface expression and virus assembly. (1995) (93)
- Antiviral effects of apolipoprotein A-I and its synthetic amphipathic peptide analogs. (1990) (92)
- Protection against lethal challenge by Ebola virus-like particles produced in insect cells. (2009) (92)
- Identification of the spike proteins of Rous sarcoma virus. (1971) (92)
- A bivalent influenza VLP vaccine confers complete inhibition of virus replication in lungs. (2008) (92)
- Stability Kinetics of Influenza Vaccine Coated onto Microneedles During Drying and Storage (2010) (91)
- Human immunodeficiency virus type 1 envelope glycoprotein is modified by O-linked oligosaccharides (1994) (91)
- Formulation of Microneedles Coated with Influenza Virus-like Particle Vaccine (2010) (91)
- Protective immunity against H5N1 influenza virus by a single dose vaccination with virus-like particles. (2010) (90)
- Location of the glycoprotein in the membrane of Sindbis virus. (1971) (90)
- Cytosolic domain of the human immunodeficiency virus envelope glycoproteins binds to calmodulin and inhibits calmodulin-regulated proteins. (1993) (89)
- Inactivation of Human Immunodeficiency Virus Type 1 by Porphyrins (2002) (88)
- Intranasal Immunization with Influenza VLPs Incorporating Membrane-Anchored Flagellin Induces Strong Heterosubtypic Protection (2010) (86)
- Incorporation of High Levels of Chimeric Human Immunodeficiency Virus Envelope Glycoproteins into Virus-Like Particles (2007) (86)
- Induction of CD4+ T-Cell-Independent Immunoglobulin Responses by Inactivated Influenza Virus (2000) (85)
- Effect of Adjuvants on Responses to Skin Immunization by Microneedles Coated with Influenza Subunit Vaccine (2012) (84)
- Reproduction of Myxoviruses (1975) (84)
- Ebola Vaccination Using a DNA Vaccine Coated on PLGA‐PLL/γPGA Nanoparticles Administered Using a Microneedle Patch (2017) (84)
- An electron microscopic study of the presence or absence of neuraminic acid in enveloped viruses. (1970) (84)
- Multiple glycoproteins synthesized by the smallest RNA segment (S10) of bluetongue virus (1992) (83)
- Effect of Antibody to Neuraminidase on the Maturation and Hemagglutinating Activity of an Influenza A2 Virus (1969) (83)
- Long-term stability of influenza vaccine in a dissolving microneedle patch (2017) (82)
- Human immunodeficiency virus-like particles activate multiple types of immune cells. (2007) (82)
- Entry and release of measles virus are polarized in epithelial cells. (1995) (82)
- Ginseng and Salviae herbs play a role as immune activators and modulate immune responses during influenza virus infection. (2007) (82)
- H1N1 influenza virus infection results in adverse pregnancy outcomes by disrupting tissue-specific hormonal regulation (2017) (81)
- Isolation and properties of the helical nucleocapsid of the parainfluenza virus SV5. (1967) (80)
- Expression of the influenza A virus M2 protein is restricted to apical surfaces of polarized epithelial cells (1992) (80)
- Nucleotide sequence conservation at the 3' termini of the virion RNA species of New World and Old World arenaviruses. (1982) (79)
- Regulation of the late events in flavivirus protein processing and maturation. (1993) (79)
- Host cell- and virus strain-dependent differences in oligosaccharides of hemagglutinin glycoproteins of influenza A viruses. (1979) (79)
- Sin Nombre virus glycoprotein trafficking. (2003) (79)
- Parainfluenza virus surface projections: glycoproteins with haemagglutinin and neuraminidase activities. (1971) (79)
- Processing of the intracellular form of the west Nile virus capsid protein by the viral NS2B-NS3 protease: an in vitro study (1994) (78)
- Influenza virus-like particles as pandemic vaccines. (2009) (78)
- Isolation and structural analysis of influenza C virion glycoproteins. (1981) (78)
- Virus-like particles as universal influenza vaccines (2012) (77)
- Assembly of animal viruses at cellular membranes. (1988) (76)
- A target site for template-based design of measles virus entry inhibitors. (2004) (76)
- Effects of hexose starvation and the role of sialic acid in influenza virus release. (1983) (75)
- Local Response to Microneedle-Based Influenza Immunization in the Skin (2012) (75)
- Vectorial release of poliovirus from polarized human intestinal epithelial cells (1993) (75)
- Immunization with a Mixture of HIV Env DNA and VLP Vaccines Augments Induction of CD8 T Cell Responses (2010) (75)
- Incorporation of Glycosylphosphatidylinositol-Anchored Granulocyte- MacrophageColony-Stimulating Factor or CD40 Ligand Enhances Immunogenicity of Chimeric Simian Immunodeficiency Virus-Like Particles (2006) (74)
- Protective Effect of Ginseng Polysaccharides on Influenza Viral Infection (2012) (74)
- Increased immunogenicity of avian influenza DNA vaccine delivered to the skin using a microneedle patch. (2012) (73)
- Structure of the influenza C glycoprotein gene as determined from cloned DNA. (1984) (73)
- Improved immunogenicity of individual influenza vaccine components delivered with a novel dissolving microneedle patch stable at room temperature (2015) (72)
- Basolateral maturation of retroviruses in polarized epithelial cells (1983) (72)
- Microneedle Delivery of H5N1 Influenza Virus-Like Particles to the Skin Induces Long-Lasting B- and T-Cell Responses in Mice (2010) (72)
- Current options for vaccine delivery systems by mucosal routes (1997) (71)
- Microneedle Vaccination with Stabilized Recombinant Influenza Virus Hemagglutinin Induces Improved Protective Immunity (2011) (70)
- Microneedle delivery of an M2e-TLR5 ligand fusion protein to skin confers broadly cross-protective influenza immunity. (2014) (70)
- DNA vaccination in the skin using microneedles improves protection against influenza. (2012) (70)
- Kinetics of Immune Responses to Influenza Virus-Like Particles and Dose-Dependence of Protection with a Single Vaccination (2009) (69)
- Influenza virus-like particles coated onto microneedles can elicit stimulatory effects on Langerhans cells in human skin. (2010) (69)
- Improved protection against avian influenza H5N1 virus by a single vaccination with virus-like particles in skin using microneedles. (2010) (69)
- Expression of the human immunodeficiency virus envelope glycoprotein is restricted to basolateral surfaces of polarized epithelial cells (1989) (69)
- Structure and Cytopathic Effects of Nelson Bay Virus (1970) (69)
- Differential effect of monensin on enveloped viruses that form at distinct plasma membrane domains (1981) (68)
- Spin-labeled electron spin resonance study of the lipid-containing membrane of influenza virus. (1971) (68)
- Stability of whole inactivated influenza virus vaccine during coating onto metal microneedles. (2013) (68)
- Mucosal Immunization with Virus-Like Particles of Simian Immunodeficiency Virus Conjugated with Cholera Toxin Subunit B (2003) (67)
- Proteolytic Cleavage of Subunits of the Nucleocapsid of the Paramyxovirus Simian Virus 5 (1974) (67)
- Hantavirus Nucleocapsid Protein Is Expressed as a Membrane-Associated Protein in the Perinuclear Region (2001) (67)
- Surface expression of influenza virus neuraminidase, an amino-terminally anchored viral membrane glycoprotein, in polarized epithelial cells (1985) (66)
- Heterosubtypic influenza protection elicited by double-layered polypeptide nanoparticles in mice (2018) (66)
- Glycopeptide components of influenza viral glycoproteins. (1978) (66)
- Multiple heterologous M2 extracellular domains presented on virus-like particles confer broader and stronger M2 immunity than live influenza A virus infection. (2013) (66)
- Organization of the lipid phase in viral membranes. Effects of independent variation of the lipid and the protein composition. (1973) (65)
- Effects of cytoplasmic domain length on cell surface expression and syncytium-forming capacity of the simian immunodeficiency virus envelope glycoprotein. (1994) (65)
- A precursor glycoprotein in influenza C virus. (1979) (65)
- Virus-like particles containing multiple M2 extracellular domains confer improved cross-protection against various subtypes of influenza virus. (2013) (63)
- Virion RNA species of the arenaviruses Pichinde, Tacaribe, and Tamiami (1978) (63)
- Palmitoylation of the Murine Leukemia Virus Envelope Protein Is Critical for Lipid Raft Association and Surface Expression (2002) (63)
- Analysis of the murine leukemia virus R peptide: delineation of the molecular determinants which are important for its fusion inhibition activity (1997) (63)
- Universal Influenza Vaccines, a Dream to Be Realized Soon (2014) (63)
- Effect of cytochalasin B on the maturation of enveloped viruses (1979) (62)
- Influenza M1 VLPs containing neuraminidase induce heterosubtypic cross-protection. (2012) (62)
- Analysis of the cell fusion activities of chimeric simian immunodeficiency virus-murine leukemia virus envelope proteins: inhibitory effects of the R peptide (1996) (62)
- Function of the KKXX Motif in Endoplasmic Reticulum Retrieval of a Transmembrane Protein Depends on the Length and Structure of the Cytoplasmic Domain* (1998) (61)
- Cross-protection by co-immunization with influenza hemagglutinin DNA and inactivated virus vaccine using coated microneedles. (2013) (60)
- A signal for Golgi retention in the bunyavirus G1 glycoprotein. (1994) (60)
- Distinct carbohydrate components of influenza virus glycoproteins in smooth and rough cytoplasmic membranes. (1973) (60)
- The human immunodeficiency virus type 1 envelope glycoprotein precursor acquires aberrant intermolecular disulfide bonds that may prevent normal proteolytic processing. (1990) (59)
- Isolation and characterization of the nonglycosylated membrane protein and a nucleocapsid complex from the paramyxovirus SV5. (1975) (59)
- Inhibition of virus‐induced cell fusion by apolipoprotein A‐I and its amphipathic peptide analogs (1991) (59)
- Modified HIV envelope proteins with enhanced binding to neutralizing monoclonal antibodies. (2005) (59)
- Serological memory and long-term protection to novel H1N1 influenza virus after skin vaccination. (2011) (58)
- Enhanced Stability of Inactivated Influenza Vaccine Encapsulated in Dissolving Microneedle Patches (2016) (58)
- Nonpeptide inhibitors of measles virus entry. (2006) (58)
- Assembly and polarized release of Punta Toro virus and effects of brefeldin A (1991) (56)
- Design of a Small-Molecule Entry Inhibitor with Activity against Primary Measles Virus Strains (2005) (56)
- Modulation of glycosylation and transport of viral membrane glycoproteins by a sodium ionophore (1983) (55)
- Long-Term Protective Immunity from an Influenza Virus-Like Particle Vaccine Administered with a Microneedle Patch (2013) (54)
- Time Course of Synthesis and Assembly of Influenza Virus Proteins (1974) (54)
- Differences in the role of the cytoplasmic domain of human parainfluenza virus fusion proteins (1995) (53)
- Expression and characterization of a functional human immunodeficiency virus envelope glycoprotein in insect cells. (1990) (53)
- Nanoclusters self-assembled from conformation-stabilized influenza M2e as broadly cross-protective influenza vaccines. (2014) (53)
- Polarized expression of a chimeric protein in which the transmembrane and cytoplasmic domains of the influenza virus hemagglutinin have been replaced by those of the vesicular stomatitis virus G protein. (1986) (53)
- Compartmentalization within the common mucosal immune system. (1995) (53)
- Sulfated components of enveloped viruses (1975) (53)
- Formation of the flavivirus envelope: role of the viral NS2B-NS3 protease (1995) (52)
- Entry of simian virus 40 is restricted to apical surfaces of polarized epithelial cells (1988) (52)
- Synthesis of mumps virus polypeptides in infected Vero cells. (1982) (52)
- Assembly of Animal Viruses at Cellular Membranes (1988) (52)
- Emergence and Evolution of Avian H5N2 Influenza Viruses in Chickens in Taiwan (2014) (52)
- The parainfluenza virus type 1 P/C gene uses a very efficient GUG codon to start its C' protein (1992) (52)
- Original Antigenic Sin Responses to Influenza Viruses (2009) (51)
- Mutations in the Cytoplasmic Domain of a Paramyxovirus Fusion Glycoprotein Rescue Syncytium Formation and Eliminate the Hemagglutinin-Neuraminidase Protein Requirement for Membrane Fusion (2003) (51)
- Enhancement of Mucosal Immunization with Virus-Like Particles of Simian Immunodeficiency Virus (2003) (51)
- Alternative mechanisms of interaction between homotypic and heterotypic parainfluenza virus HN and F proteins. (1999) (51)
- Mutations in the Putative HR-C Region of the Measles Virus F2 Glycoprotein Modulate Syncytium Formation (2003) (51)
- Structural components of influenza C virions (1977) (51)
- Production and characterization of simian--human immunodeficiency virus-like particles. (2000) (51)
- Host responses from innate to adaptive immunity after vaccination: Molecular and cellular events (2009) (51)
- Tetanus vaccination with a dissolving microneedle patch confers protective immune responses in pregnancy. (2016) (50)
- Two Domains That Control Prefusion Stability and Transport Competence of the Measles Virus Fusion Protein (2006) (49)
- Golgi complex localization of the Punta Toro virus G2 protein requires its association with the G1 protein (1991) (49)
- Supplementation of influenza split vaccines with conserved M2 ectodomains overcomes strain specificity and provides long-term cross protection. (2014) (49)
- Association of the internal membrane protein with the lipid bilayer in influenza virus. A study with the fluorescent probe 12-(9-anthroyl)-stearic acid (1974) (49)
- Structural components of the arenavirus Pichinde (1977) (49)
- The Structure and Assembly of Influenza and Parainfluenza Viruses (1971) (48)
- Virus-like particle and DNA-based candidate AIDS vaccines. (2003) (48)
- Influenza Virus-Specific Neutralizing IgM Antibodies Persist for a Lifetime (2014) (48)
- Enhanced Influenza Virus-Like Particle Vaccines Containing the Extracellular Domain of Matrix Protein 2 and a Toll-Like Receptor Ligand (2012) (48)
- Influenza B and Influenza C Viruses (1983) (48)
- Induction of HIV Neutralizing Antibodies against the MPER of the HIV Envelope Protein by HA/gp41 Chimeric Protein-Based DNA and VLP Vaccines (2011) (48)
- Microencapsulated human parainfluenza virus induces a protective immune response. (1993) (47)
- Malaria: Drugs, Disease and Post-genomic Biology (2005) (47)
- Intranasal Immunization with Inactivated Influenza Virus Enhances Immune Responses to Coadministered Simian-Human Immunodeficiency Virus-Like Particle Antigens (2004) (47)
- Oligopeptide inhibitors of HIV-induced syncytium formation. (1990) (46)
- Immunization by influenza virus-like particles protects aged mice against lethal influenza virus challenge. (2009) (46)
- Molecular domains involved in oligomerization of the Friend murine leukemia virus envelope glycoprotein. (1991) (46)
- Monoclonal antibodies reveal extensive antigenic differences between the hemagglutinin-neuraminidase glycoproteins of human and bovine parainfluenza 3 viruses. (1986) (46)
- Intracellular accumulation of punta toro virus glycoproteins expressed from cloned cDNA (1988) (46)
- MyD88 Plays an Essential Role in Inducing B Cells Capable of Differentiating into Antibody-Secreting Cells after Vaccination (2011) (45)
- Intranasal immunization with SIV virus-like particles (VLPs) elicits systemic and mucosal immunity. (2002) (45)
- Less Is More: Ebola Virus Surface Glycoprotein Expression Levels Regulate Virus Production and Infectivity (2014) (45)
- Regulation of fusion activity by the cytoplasmic domain of a paramyxovirus F protein. (2002) (45)
- Glycoproteins of human parainfluenza virus type 3: characterization and evaluation as a subunit vaccine. (1985) (45)
- Novel vaccines against influenza viruses. (2011) (45)
- Incorporation of sulfate into influenza virus glycoproteins. (1975) (44)
- Effect of membrane protein on lipid bilayer structure: a spin-label electron spin resonance study of vesicular stomatitis virus. (1976) (44)
- Expression of herpes simplex virus glycoproteins in polarized epithelial cells (1986) (44)
- Delayed appearance of pseudotypes between vesicular stomatitis virus influenza virus during mixed infection of MDCK cells (1981) (43)
- Structural proteins of Tacaribe and Tamiami virions. (1977) (43)
- The formation of poliovirus particles in association with the RNA replication complexes. (1973) (43)
- Biodegradable microspheres for the delivery of oral vaccines (1994) (42)
- Immune response to human influenza virus hemagglutinin expressed in Escherichia coli. (1983) (42)
- Hemagglutination-Inhibition: Rapid Assay for Neuraminic Acid-Containing Viruses (1974) (42)
- Virus entry and release in polarized epithelial cells. (1995) (42)
- Bunyavirus protein transport and assembly. (1991) (42)
- Assembly and release of SIV env proteins with full-length or truncated cytoplasmic domains. (1996) (41)
- Targeting the skin for microneedle delivery of influenza vaccine. (2013) (41)
- Pause on avian flu transmission research. (2012) (41)
- Structural features of paramyxovirus F protein required for fusion initiation. (2003) (41)
- Oligomerization, transport, and Golgi retention of Punta Toro virus glycoproteins (1991) (40)
- The cellular site of sulfation of influenza viral glycoproteins. (1977) (40)
- The nucleic acid of the parainfluenza virus SV5. (1968) (40)
- Structural domains of vesicular stomatitis virus. A study by differential scanning calorimetry, thermal gel analysis, and thermal electron microscopy. (1982) (40)
- Nonpolarized expression of a secreted murine leukemia virus glycoprotein in polarized epithelial cells (1986) (40)
- Immune responses to influenza virus in orally and systemically immunized mice. (1989) (40)
- Salmonella flagellin enhances mucosal immunity of avian influenza vaccine in chickens. (2012) (40)
- Human immunodeficiency virus type 2 envelope glycoprotein: differential CD4 interactions of soluble gp120 versus the assembled envelope complex. (1992) (39)
- Emerged HA and NA Mutants of the Pandemic Influenza H1N1 Viruses with Increasing Epidemiological Significance in Taipei and Kaohsiung, Taiwan, 2009–10 (2012) (39)
- Glycosylation sites of influenza viral glycoproteins: characterization of tryptic glycopeptides from the A/USSR(H1N1) hemagglutinin glycoprotein (1981) (39)
- Influenza immunization with trehalose-stabilized virus-like particle vaccine using microneedles. (2010) (39)
- Role of individual glycoproteins of human parainfluenza virus type 3 in the induction of a protective immune response (1988) (39)
- Biosynthesis of the oligosaccharides of influenza viral glycoproteins. (1979) (39)
- Palmitoylation of the murine leukemia virus envelope glycoprotein transmembrane subunits. (1996) (39)
- Secretion of a truncated form of the human immunodeficiency virus type 1 envelope glycoprotein. (1993) (38)
- The length of the helical nucleocapsid of Newcastle disease virus. (1967) (38)
- Characterization of the RNA associated with influenza A cytoplasmic inclusions and the interaction of NS1 protein with RNA. (1981) (38)
- Replication and morphogenesis of avian coronavirus in Vero cells and their inhibition by monensin (1984) (38)
- Vesicular Stomatitis Virus G Protein Acquires pH-Independent Fusion Activity during Transport in a Polarized Endometrial Cell Line (1999) (38)
- Transmission Studies Resume for Avian Flu (2013) (37)
- Prevention of HIV-1 infection by phthalocyanines. (2003) (37)
- Surface Stability and Immunogenicity of the Human Immunodeficiency Virus Envelope Glycoprotein: Role of the Cytoplasmic Domain (2004) (37)
- Characterization of simian virus 40 receptor moieties on the surfaces of Vero C1008 cells (1989) (37)
- Expression of the fusion glycoprotein of human parainfluenza type 3 virus in insect cells by a recombinant baculovirus and analysis of its immunogenic property. (1989) (37)
- Sialic acid is incorporated into influenza hemagglutinin glycoproteins in the absence of viral neuraminidase. (1985) (36)
- The short Sendai virus leader region controls induction of programmed cell death. (1998) (36)
- Enhanced immune responses by skin vaccination with influenza subunit vaccine in young hosts (2015) (36)
- Host Responses in Human Skin After Conventional Intradermal Injection or Microneedle Administration of Virus‐Like‐Particle Influenza Vaccine (2013) (35)
- Filamentous particle formation by human parainfluenza virus type 2. (2000) (35)
- Intracellular Interaction of Simian Immunodeficiency Virus Gag and Env Proteins (1999) (35)
- Intranasal immunization of hamsters with envelope glycoproteins of human parainfluenza virus type 3. (1988) (35)
- Polarized entry of canine parvovirus in an epithelial cell line (1989) (34)
- Synthesis of tacaribe viral proteins. (1979) (34)
- Botulinum Neurotoxins (2013) (34)
- Evidence for Cooperation between Murine Leukemia Virus Env Molecules in Mixed Oligomers (1998) (33)
- Sulfonated naphthyl porphyrins as agents against HIV-1. (2005) (33)
- Stable incorporation of GM-CSF into dissolvable microneedle patch improves skin vaccination against influenza (2018) (33)
- Effect of Osmotic Pressure on the Stability of Whole Inactivated Influenza Vaccine for Coating on Microneedles (2015) (33)
- Biochemistry of arenaviruses. (1985) (33)
- Changes in Human Langerhans Cells Following Intradermal Injection of Influenza Virus-Like Particle Vaccines (2010) (33)
- A case of syncytial giant cell hepatitis with features of a paramyxoviral infection (1998) (33)
- Gain-of-Function Experiments on H7N9 (2013) (33)
- Pause on Avian Flu Transmission Research (2012) (32)
- Isolation and Properties of an RNA Polymerase from Influenza Virus-Infected Cells (1973) (32)
- Molecular determinants of Golgi retention in the Punta Toro virus G1 protein. (1996) (31)
- Intranasal vaccination with influenza HA/GO-PEI nanoparticles provides immune protection against homo- and heterologous strains (2021) (31)
- Effect of the Cytoplasmic Domain of the Simian Immunodeficiency Virus Envelope Protein on Incorporation of Heterologous Envelope Proteins and Sensitivity to Neutralization (2000) (31)
- Structural components of mouse mammary tumor virus. I. Polypeptides of the virion. (1977) (31)
- Activation of Fusion by the SER Virus F Protein: a Low-pH-Dependent Paramyxovirus Entry Process (2003) (31)
- Influenza Pathogenesis and Control - Volume I (2014) (31)
- Isolation and characterization of cytoplasmic inclusions from influenza A virus-infected cells (1978) (31)
- Effect of tunicamycin on the replication of Sendai virus. (1982) (31)
- Delivery of DNA HIV-1 vaccine to the liver induces high and long-lasting humoral immune responses. (2008) (31)
- Virus-Like Particle Vaccine Containing Hemagglutinin Confers Protection against 2009 H1N1 Pandemic Influenza (2011) (31)
- Isolation of an arenavirus from a marmoset with callitrichid hepatitis and its serologic association with disease (1991) (30)
- Release of virus-like particles from cells infected with poliovirus replicons which express human immunodeficiency virus type 1 Gag (1996) (30)
- Adjuvanted Influenza Vaccine Administered Intradermally Elicits Robust Long-Term Immune Responses that Confer Protection from Lethal Challenge (2010) (30)
- Production of Potent Fully Human Polyclonal Antibodies against Ebola Zaire Virus in Transchromosomal Cattle (2016) (29)
- Additive protection induced by mixed virus-like particles presenting respiratory syncytial virus fusion or attachment glycoproteins. (2014) (29)
- Multi-envelope HIV vaccine safety and immunogenicity in small animals and chimpanzees (2000) (29)
- Mucosal adjuvants for influenza virus-like particle vaccine. (2013) (29)
- The NS and capsid genes determine the host range of porcine parvovirus. (1992) (29)
- Bidirectional entry of poliovirus into polarized epithelial cells (1993) (29)
- Prevention of HIV-1 infection by platinum triazines. (2005) (29)
- Polarized Apical Targeting Directed by the Signal/Anchor Region of Simian Virus 5 Hemagglutinin-Neuraminidase* (1997) (29)
- Inhibition of human immunodeficiency virus type 1-induced cell fusion by recombinant human interferons (1991) (28)
- Immunogenicity of low-pH treated whole viral influenza vaccine. (2011) (28)
- Cutaneous immunization: an evolving paradigm in influenza vaccines (2014) (28)
- Studies on the role of glycosylation in the functions and antigenic properties of influenza virus glycoproteins. (1983) (28)
- Effects of monensin on morphogenesis and infectivity of Friend murine leukemia virus (1982) (28)
- Upregulation of signalase processing and induction of prM-E secretion by the flavivirus NS2B-NS3 protease: roles of protease components (1997) (28)
- Immunogenicity of virus-like particles containing modified human immunodeficiency virus envelope proteins. (2007) (28)
- Proteomic characterization of influenza H5N1 virus-like particles and their protective immunogenicity. (2011) (27)
- Cell fusion induced by Nelson Bay virus. (1982) (27)
- HIV envelope proteins differentially utilize CXCR4 and CCR5 coreceptors for induction of apoptosis. (2001) (27)
- Analysis of the In Vitro Product of an RNA-Dependent RNA Polymerase Isolated from Influenza Virus-Infected Cells (1974) (27)
- Membrane association and defective transport of spleen focus-forming virus glycoproteins. (1983) (27)
- Antibody-resistant spread of vesicular stomatitis virus infection in cell lines of epithelial origin (1980) (26)
- Glycosylation sites of influenza viral glycoproteins. Tryptic glycopeptides from the A/WSN (H0N1) hemagglutinin glycoprotein. (1980) (26)
- Migration of polarized epithelial cells through permeable membrane substrates of defined pore size. (1992) (26)
- Memory T Cells Generated by Prior Exposure to Influenza Cross React with the Novel H7N9 Influenza Virus and Confer Protective Heterosubtypic Immunity (2015) (26)
- Posttranslational modification and intracellular transport of mumps virus glycoproteins (1983) (25)
- Multiple domains of the SIV Env protein determine virus replication efficiency and neutralization sensitivity. (2005) (25)
- Defective interfering Tacaribe virus and persistently infected cells. (1980) (25)
- Coated protein nanoclusters from influenza H7N9 HA are highly immunogenic and induce robust protective immunity. (2017) (25)
- Chimeric virus-like particles containing influenza HA antigen and GPI-CCL28 induce long-lasting mucosal immunity against H3N2 viruses (2017) (25)
- Introduction: rotavirus--from basic research to a vaccine. (1996) (24)
- Induction of immune responses to SIV antigens by mucosally administered vaccines. (1999) (24)
- Enhancement of immunogenicity of an HIV Env DNA vaccine by mutation of the Tyr-based endocytosis motif in the cytoplasmic domain. (2004) (24)
- Isolation and characterization of ribonucleoprotein substructures from Rous sarcoma virus. (1972) (24)
- Chimeric influenza virus hemagglutinin containing either the NH2 terminus or the COOH terminus of G protein of vesicular stomatitis virus is defective in transport to the cell surface. (1984) (24)
- Sulfation of the human immunodeficiency virus envelope glycoprotein (1992) (24)
- Protection against filovirus infection: virus-like particle vaccines (2008) (24)
- Oral vaccination with inactivated influenza vaccine induces cross-protective immunity. (2012) (24)
- Virus-Like Particles Containing the Tetrameric Ectodomain of Influenza Matrix Protein 2 and Flagellin Induce Heterosubtypic Protection in Mice (2013) (24)
- Effects of Filipin on the Structure and Biological Activity of Enveloped Viruses (1977) (24)
- The env protein of an infectious noncytopathic HIV-2 is deficient in syncytium formation. (1990) (23)
- The replication of negative strand viruses : proceedings of the 4th International Symposium on Negative Strand Viruses held October 26-November 1, 1980 at Frenchman's Reef, Saint Thomas, U.S. Virgin Islands (1981) (23)
- Enhancement of mucosal immune responses by chimeric influenza HA/SHIV virus-like particles. (2003) (23)
- The organization of the proteins of vesicular stomatitis virions: labeling with pyridoxal phosphate. (1975) (23)
- Incorporation of a GPI-anchored engineered cytokine as a molecular adjuvant enhances the immunogenicity of HIV VLPs (2015) (22)
- Virus-like particles in MDCK cells persistently infected with Borna disease virus (1994) (22)
- Prevention of poxvirus infection by tetrapyrroles (2003) (22)
- Basolateral sorting of the HIV type 2 and SIV envelope glycoproteins in polarized epithelial cells: role of the cytoplasmic domain. (1997) (22)
- Assembly of lipid-containing viruses. (1974) (22)
- Intradermal immunization by Ebola virus GP subunit vaccines using microneedle patches protects mice against lethal EBOV challenge (2018) (22)
- Skin immunization with influenza vaccines. (2015) (22)
- Preliminary X-ray crystallographic analysis of canine parvovirus crystals. (1988) (22)
- Effects of deletion of the cytoplasmic domain upon surface expression and membrane stability of a viral envelope glycoprotein. (1987) (21)
- Carbohydrate Components of Influenza C Virions (1979) (21)
- Structure of the lipid phase of Rauscher murine leukemia virus. (1972) (21)
- Protein transfer-mediated surface engineering to adjuvantate virus-like nanoparticles for enhanced anti-viral immune responses. (2015) (21)
- Replication and plaque assay of influenza C virus in chicken kidney cells (1979) (21)
- Basolateral expression of a chimeric protein in which the transmembrane and cytoplasmic domains of vesicular stomatitis virus G protein have been replaced by those of the influenza virus hemagglutinin. (1987) (21)
- Protocatechuic Acid, a Novel Active Substance against Avian Influenza Virus H9N2 Infection (2014) (21)
- The spleen focus-forming virus envelope glycoprotein is defective in oligomerization. (1989) (21)
- Protein sorting in polarized epithelial cells. (1991) (20)
- A protective role of murine langerin+ cells in immune responses to cutaneous vaccination with microneedle patches (2014) (20)
- Arenavirus Ultrastructure and Morphogenesis (1993) (20)
- Polypeptide composition of incomplete influenza virus grown in MDBK cells. (1975) (20)
- Induction of Influenza-Specific Mucosal Immunity by an Attenuated Recombinant Sendai Virus (2011) (20)
- Human parainfluenza virus induces a type-specific protective immune response. (1990) (20)
- Mutations in the Cytoplasmic Tail of Murine Leukemia Virus Envelope Protein Suppress Fusion Inhibition by R Peptide (2001) (20)
- Permeability properties of the membrane of vesicular stomatitis virions. (1976) (19)
- Glycosylation and intracellular transport of spleen focus-forming virus glycoproteins. (1983) (19)
- Murine Leukemia Virus R Peptide Inhibits Influenza Virus Hemagglutinin-Induced Membrane Fusion (2006) (18)
- A polarized human endometrial cell line that binds and transports polymeric IgA (1995) (18)
- Glycopeptides of Murine Leukemia Viruses I. Comparison of Two Ecotropic Viruses (1979) (18)
- Gene products of influenza C virus (1980) (18)
- Mutations in Multiple Domains Activate Paramyxovirus F Protein-Induced Fusion (2004) (18)
- Immunogenicity of full length and truncated SIV envelope proteins. (1999) (18)
- The sense of the helix of paramyxovirus nucleocapsids. (1972) (18)
- Glycoproteins of human parainfluenza virus type 3: affinity purification, antigenic characterization and reconstitution into lipid vesicles. (1987) (18)
- Microneedle patch delivery of influenza vaccine during pregnancy enhances maternal immune responses promoting survival and long-lasting passive immunity to offspring (2017) (17)
- Expression of SV40 receptors on apical surfaces of polarized epithelial cells. (1992) (17)
- Alternate pathways of secretion of simian immunodeficiency virus envelope glycoproteins (1993) (17)
- Glycopeptides of murine leukemia viruses. II. Comparison of xenotropic and dual-tropic viruses (1980) (17)
- Parameters of inhibition of HIV-1 infection by small anionic microbicides. (2007) (17)
- Three membrane-proximal amino acids in the human parainfluenza type 2 (HPIV 2) F protein are critical for fusogenic activity. (2001) (17)
- Oligomerization, secretion, and biological function of an anchor-free parainfluenza virus type 2 (PI2) fusion protein. (2000) (17)
- Intracellular Targeting and Assembly of Paramyxovirus Proteins (1991) (17)
- The complete nucleotide sequence of an infectious clone of porcine parvovirus, strain NADL-2. (1990) (17)
- Combination of STING Pathway Agonist With Saponin Is an Effective Adjuvant in Immunosenescent Mice (2019) (16)
- Intradermal Vaccination With Adjuvanted Ebola Virus Soluble Glycoprotein Subunit Vaccine by Microneedle Patches Protects Mice Against Lethal Ebola Virus Challenge. (2018) (16)
- Polarization of viral entry and release in epithelial cells (1996) (16)
- Membrane Glycoproteins of Enveloped Viruses (1978) (16)
- The hydrophobic membrane-spanning sequences of the gp52 glycoprotein are required for the pathogenicity of Friend spleen focus-forming virus (1991) (16)
- Enhancement of mucosal immune responses to the influenza virus HA protein by alternative approaches to DNA immunization. (1999) (15)
- Co-delivery of GPI-anchored CCL28 and influenza HA in chimeric virus-like particles induces cross-protective immunity against H3N2 viruses. (2016) (15)
- Effects of modification of the HIV-1 Env cytoplasmic tail on immunogenicity of VLP vaccines. (2016) (15)
- A case of syncytial giant cell hepatitis with features of a paramyxoviral infection. (1998) (15)
- Extended delivery of vaccines to the skin improves immune responses (2019) (15)
- Characterization of Immune Responses Induced by Ebola Virus Glycoprotein (GP) and Truncated GP Isoform DNA Vaccines and Protection Against Lethal Ebola Virus Challenge in Mice. (2015) (15)
- Role of the long cytoplasmic domain of the SIV Env glycoprotein in early and late stages of infection (2007) (14)
- Comparative analysis of oral delivery systems for live rotavirus vaccines (1996) (14)
- Analysis of polypeptides in Tacaribe virus-infected cells. (1983) (14)
- EFFECT OF CYTOCHALASIN B ON THE (1979) (14)
- Intracellular transport and leukemogenicity of spleen focus-forming virus envelope glycoproteins with altered transmembrane domains (1987) (14)
- Glycopeptides of Murine Leukemia Viruses III. Glycosylation of env Precursor Glycoproteins (1981) (13)
- Enhanced cellular immune response against SIV Gag induced by immunization with DNA vaccines expressing assembly and release-defective SIV Gag proteins. (2003) (13)
- Skin immunization by microneedle patch overcomes statin-induced suppression of immune responses to influenza vaccine (2017) (13)
- Inhibition of influenza C virus replication by actinomycin D, alpha-amanitin, and UV irradiation (1979) (13)
- Sequence of the hemagglutinin-neuraminidase gene of human parainfluenza virus type 1. (1990) (13)
- Development of a rubella virus DNA vaccine. (1999) (13)
- Co-Delivery of M2e Virus-Like Particles with Influenza Split Vaccine to the Skin Using Microneedles Enhances the Efficacy of Cross Protection (2019) (13)
- Immunologic studies on the influenza A virus nonstructural protein NS1 (1982) (13)
- PROTEINS OF VESICULAR STOMATITIS VIRUS (VSV) AND OF PHENOTYPICALLY-MIXED VSV-SV5 VIRIONS. (1972) (12)
- Antigenic properties of a transport-competent influenza HA/HIV Env chimeric protein. (2006) (12)
- Atypical Fusion Peptide of Nelson Bay Virus Fusion-Associated Small Transmembrane Protein (2005) (12)
- Virus Infection of Epithelial Cells (2005) (12)
- Surface expression of a nonstructural antigen on influenza A virus-infected cells (1981) (12)
- Mucosal immunity and strategies for novel microbial vaccines (1994) (12)
- Expression of the spleen focus-forming virus envelope gene in a polarized epithelial cell line. (1988) (12)
- Adaptation of measles virus to polarized epithelial cells: alterations in virus entry and release. (1997) (12)
- Selective dansylation of M protein within intact influenza virions (1982) (12)
- Reverse Phase Ion Pair High Performance Liquid Chromatography of Viral Tryptic Glycopeptides (1981) (11)
- Structure of the membrane protein of influenza virus. I. Isolation and characterization of cyanogen bromide cleavage products (1979) (11)
- Observations on the membrane organization of standard and incomplete influenza grown in MDBK cells. (1976) (11)
- Origin of the minor glycoproteins of murine leukemia viruses (1978) (11)
- Mucosal immunization of CD4+ T cell-deficient mice with an inactivated virus induces IgG and IgA responses in serum and mucosal secretions. (2005) (11)
- Host cell-dependent lateral mobility of viral glycoproteins. (1990) (11)
- Enhancement of immune responses to an HIV env DNA vaccine by a C-terminal segment of listeriolysin O. (2003) (11)
- Calmodulin antagonists inhibit human immunodeficiency virus-induced cell fusion but not virus replication. (1994) (11)
- The envelope glycoprotein of simian immunodeficiency virus contains an enterotoxin domain. (2000) (10)
- Nucleotide sequence analysis of the capsid genes and the right-hand terminal palindrome of porcine parvovirus, strain NADL-2. (1989) (10)
- Structure and glycosylation of Tacaribe viral glycoproteins. (1982) (10)
- Immunobiology and pathogenesis of persistent virus infections (1996) (10)
- Universal Influenza Vaccines - A Short Review (2013) (10)
- Population biology, evolution, and immunology of vaccination and vaccination programs. (1998) (10)
- Characterization of visna virus envelope neuraminic acid (1977) (9)
- Coreceptor-Dependent Inhibition of the Cell Fusion Activity of Simian Immunodeficiency Virus Env Proteins (2000) (9)
- Role of the cytoplasmic domains of viral glycoproteins in antibody-induced cell surface mobility (1993) (9)
- cGAMP/Saponin Adjuvant Combination Improves Protective Response to Influenza Vaccination by Microneedle Patch in an Aged Mouse Model (2021) (9)
- Synthesis of Tacaribe virus polypeptides in an in vitro coupled transcription and translation system. (1985) (9)
- A 585-bp deletion found in the spleen focus-forming virus (SFFV) env gene is responsible for the defective intracellular transport of SFFV gp52. (1992) (8)
- Virus-Like Particle Vaccine Protects against 2009 H 1 N 1 Pandemic Influenza Virus in Mice (8)
- In Vitro Synthesis of Proteins by Membrane-Bound Polyribosomes from Vesicular Stomatitis Virus-Infected HeLa Cells (8)
- Nonsegmented negative strand viruses : paramyxoviruses and rhabdoviruses (1984) (8)
- Immunobiology of Natural Killer Cell Receptors (2006) (8)
- Structural components of mouse mammary tumor virus. III. Composition and tryptic peptides of virion polypeptides. (1978) (8)
- Effects of stabilization of the gp41 cytoplasmic domain on fusion activity and infectivity of SIVmac239. (2011) (7)
- DIRECTIONAL TRANSPORT OF VIRAL GLYCOPROTEINS IN POLARIZED EPITHELIAL CELLS (1981) (7)
- Structural components of mouse mammary tumor virus. II. Isolation and purification of virion polypeptides (1978) (7)
- Fabrication of microneedle patches with lyophilized influenza vaccine suspended in organic solvent (2021) (7)
- Characterization of a novel baboon virus closely resembling human T-cell leukemia virus. (1996) (7)
- Vaccination with Combination DNA and Virus-Like Particles Enhances Humoral and Cellular Immune Responses upon Boost with Recombinant Modified Vaccinia Virus Ankara Expressing Human Immunodeficiency Virus Envelope Proteins (2017) (7)
- Gain-of-function experiments on H7N9. (2013) (7)
- Reverse phase ion-pair chromatography of viral glycopeptides (1979) (6)
- Chapter 1 Viruses as Model Systems in Cell Biology (1994) (6)
- Structural domains in vesicular stomatitis virus membrane as studied by differential scanning calorimetry. (1982) (6)
- Molecular cloning and sequence analysis of the fusion glycoprotein gene of human parainfluenza virus type 2. (1990) (6)
- An amphipathic sequence in the cytoplasmic tail of HIV-1 Env alters cell tropism and modulates viral receptor specificity. (2015) (6)
- Summary of the Fifth Rotavirus Vaccine Workshop. (1996) (6)
- Enveloped Virus Maturation at Restricted Membrane Domains (1984) (6)
- Closely Related Influenza Viruses Induce Contrasting Respiratory Tract Immunopathology (2013) (6)
- NUCLEOCAPSID PROTEIN SUBUNITS OF SV5, NEWCASTLE DISEASE VIRUS AND SENDAI VIRUS. (1971) (6)
- Segmented negative strand viruses : arenaviruses, bunyaviruses, and orthomyxoviruses (1984) (5)
- Vaccines for Pandemic Influenza (2009) (5)
- Oncogenes and Retroviruses (1989) (5)
- Bivalent vaccination with NA1 and NA2 neuraminidase virus-like particles is protective against challenge with H1N1 and H3N2 influenza A viruses in a murine model. (2021) (5)
- Modulation of influenza vaccine immune responses using an epidermal growth factor receptor kinase inhibitor (2015) (5)
- CD4+CD25+ regulatory T cells : origin, function and therapeutic potential (2005) (5)
- Separation of influenza hemagglutinin tryptic glycopeptides by ion-pair reverse-phase high-performance liquid chromatography (HPLC). (1980) (4)
- Distinct B‐cell populations contribute to vaccine antigen‐specific antibody production in a transgenic mouse model (2014) (4)
- Generation of long flavivirus expression cassettes by in vivo recombination and transient dominant selection. (1994) (4)
- VLP vaccines and effects of HIV-1 Env protein modifications on their antigenic properties (2016) (4)
- Lentiviral Vectors Pseudotyped with Envelope Glycoproteins Derived from Human Parainfluenza Virus Type 3 (2004) (4)
- Structure and variation of the influenza C glycoprotein. (1985) (4)
- Adaptive immunity mediated by Natural Killer cells. (2012) (4)
- Influenza pathogenesis and control (2014) (4)
- Improved separation of glycosylated tryptic peptides by RP‐HPLC (1981) (4)
- STRUCTURE OF THE SPIKE GLYCOPROTEIN OF INFLUENZA C VIRUS (1981) (4)
- Isotype of anti-SIV responses in infected rhesus macaques and in animals immunized by mucosal routes. (1992) (4)
- Double-layered protein nanoparticles induce broad protection against divergent influenza A viruses (2018) (4)
- Assembly of G1 and G2 glycoprotein oligomers in Punta Toro virus-infected cells☆ (1992) (3)
- Cutaneous vaccination ameliorates Zika virus-induced neuro-ocular pathology via reduction of anti-ganglioside antibodies (2020) (3)
- “Cytoplasmic domain effects on exposure of co-receptor-binding sites of HIV-1 Env” (2016) (3)
- Cell biology of virus entry, replication and pathogenesis (1992) (3)
- RESTRICTED MOBILITY OF INFLUENZA HEMAGGLUTININ ON HELA CELL PLASMA MEMBRANES (1984) (3)
- Enhanced memory responses to H1N1 influenza vaccination in the skin using vaccine coated-microneedles (3)
- Mucosal Vaccines (2012) (3)
- Fusogenic Variants of a Noncytopathic Paramyxovirus (2007) (2)
- VARIATION OF GLYCOSYLATION SITES IN H 1 N 1 STRAINS OF INFLUENZA VIRUS (1981) (2)
- Adjuvants for Skin Vaccination (2017) (2)
- Structural Components ofInfluenza C Virions (1977) (2)
- Protein Traffic in Eukaryotic Cells (1991) (2)
- Corrigendum to "Protection against lethal challenge by Ebola virus-like particles produced in insect cells" [Virology 383 (2009) 12-21]. (2010) (1)
- Immune stimulation following microneedle delivery of influenza virus-like particle (VLP) vaccines to human skin (2010) (1)
- TRANSPORT OF VIRAL GLYCOPROTEINS AND ITS MODULATION BY MONENSIN 1 1 This work was supported by NIH grants AI 12680 and AI07150, and NSF grant PCM 80-06498. (1984) (1)
- A carboxy-terminal mutant spleen focus-forming virus (SFFV) envelope glycoprotein is transport-competent, but non-leukemogenic. (1992) (1)
- Lentivirus vector pseudotyped with human parainfluenza virus type 3 glycoproteins (2002) (1)
- Are long-term influenza vaccines possible and how do we discover them? (2020) (1)
- Lentiviral vectors pseudotyped with envelope glycoproteins derived from human parainfluenza virus type 3. (2004) (1)
- Characterization of glycosaminoglycans associated with Rauscher murine leukemia virions. (1982) (1)
- Vaccines for pandemic influenza. Preface. (2009) (1)
- “Cytoplasmic domain effects on exposure of co-receptor-binding sites of HIV-1 Env” (2016) (1)
- Incorporation of GPI-anchored GM-CSF or CD 40 ligand enhances immunogenicity of chimeric simian immunodeficiency virus-like particles (2006) (1)
- Intradermal Immunization of EBOV VLPs in Guinea Pigs Induces Broader Antibody Responses Against GP Than Intramuscular Injection (2020) (1)
- Effect of influenza A virus M2 protein on virus assembly and release (1996) (1)
- Amphipathic Helical Peptides Derived from the C-Terminus of the HIV Glycoprotein Interact with Membranes and Inhibit Virus-Induced Cell Fusion, (1992) (0)
- GPI-GM-CSF protein transferred onto H5 influenza VLPs remains stably expressed and functionally active (P6168) (2013) (0)
- VirusesOriginal Antigenic Sin Responses to Influenza (2009) (0)
- Microneedle patch delivery of influenza vaccine during pregnancy enhances maternal immune responses promoting survival and long-lasting passive immunity to offspring (2017) (0)
- Virus-Like Particle Vaccine Induces Protective Immunity against Homologous and Heterologous Strains of Influenza Virus (cid:1) (2007) (0)
- Fusogenic Variants of a Noncytopathic Paramyxovirus (cid:1) (2007) (0)
- Isolation andProperties ofanRNA Polymerase fromInfluenza Virus-Infected Cells (1973) (0)
- Influenza Viruses in Chickens in Taiwan Emergence and Evolution of Avian H5N2 (2014) (0)
- Dissolving polymer microneedle patches for influenza vaccination — Source link (0)
- Systems Biology (2013) (0)
- Influenza prevention during pregnancy (2016) (0)
- Effects ofMonensin on Morphogenesis andInfectivity of Friend MurineLeukemia Virus (1982) (0)
- 0 . 4 M NaCl-0 . 05 M Tris-hydrochloride-5 mM EDTA (0)
- Influenza A virus pathogenesis: Identification of host factors that contribute to severe respiratory distress (169.18) (2012) (0)
- Antigenic Sin Responses to Influenza Joshy (2009) (0)
- Systemic dysregulation of cellular immune responses to H1N1 infection during pregnancy (2016) (0)
- Depressed specific antibody response in mice induced by primary inoculation with polyoma tumor cells. Abstr. (1979) (0)
- VLP vaccines and effects of HIV-1 Env protein modifications on their antigenic properties (2016) (0)
- Long-term stability of influenza vaccine in a dissolving microneedle patch (2016) (0)
- Cell surface expression of chimeric influenza hemagglutinin (HA) and vesicular stomatitis G proteins (1985) (0)
- Polarized expression of viral glycoproteins in epithelial cells infected with recombinant vaccinia virus vectors (1985) (0)
- Harnessing Sendai virus to induce mucosal immunity (113.32) (2012) (0)
- Peptide analogs of the human parainfluenza virus fusion protein inhibit viral fusion and virus infection (1997) (0)
- SCAD (Avian Diseases) II (2011) (0)
- Alternate Pathways ofSecretion ofSimianImmunodeficiency VirusEnvelope Glycoproteins (1993) (0)
- Correction: Changes in Human Langerhans Cells Following Intradermal Injection of Influenza Virus-Like Particle Vaccines (2010) (0)
- Apoptosis in Immunology (1995) (0)
- Incorporation of High Levels of Chimeric Human Immunodeficiency Virus Envelope Glycoproteins into Virus-Like Particles (cid:1) (2007) (0)
- Harnessing Sendai virus to induce mucosal immunity (2012) (0)
- Current Topics in Microbiology and Immunology 129 (1986) (0)
- GPI-anchored CCL28 as a strong mucosal immunostimulator with influenza VLPs (2016) (0)
- Taiwan's Response to Influenza: A Seroepidemiological Evaluation of Policies and Implications for Pandemic Preparedness. (2022) (0)
- Influenza Virus Pandemic Swine-Origin 2009 A (H1N1) Viruses Confers Cross-Protection against the Immunity to Pre-1950 H1N1 Influenza (2010) (0)
- Cutaneous immunization: an evolving paradigm in influenza (2014) (0)
- CHAPTER 3 Reproduction of Myxoviruses (0)
- Adaptive immunity mediated by Natural Killer cells. (45.20) (2012) (0)
- Table of Contents (1986) (0)
- Fabrication of microneedle patches with lyophilized influenza vaccine suspended in organic solvent (2021) (0)
- 17 Expression of Viral Receptors and the Vectorial Release of Viruses in Polarized Epithelial Cells (1994) (0)
- Porphyrines a activite virucide (2003) (0)
- The 2011 JALA Ten (2011) (0)
- TRANSPORT OF VIRAL GLYCOPROTEINS AND ITS MODULATION BY MONENSIN1 (2013) (0)
- Enhanced Stability of Inactivated Influenza Vaccine Encapsulated in Dissolving Microneedle Patches (2015) (0)
- Oligonucleotide fingerprint analysis of Tacaribe virion RNA. (1981) (0)
- Proteins ofVesicular Stomatitis Virusandof Phenotypically MixedVesicular Stomatitis Virus-Simian Virus5Virions' (1971) (0)
- Adjuvanting influenza virus-like particles with glycophosphatidylinosital-anchored immunostimulatory molecules by protein transfer to enhance antiviral immune responses (106.14) (2011) (0)
- Adjuvant characterization for virus-like particle-based influenza vaccines (2008) (0)
- Improved immunogenicity of individual influenza vaccine components delivered with a novel dissolving microneedle patch stable at room temperature (2015) (0)
- RoleoftheCytoplasmic DomainsofViral Glycoproteins in Antibody-Induced CellSurface Mobility (1993) (0)
- Intradermal immunization by Ebola virus GP subunit vaccines using microneedle patches protects mice against lethal EBOV challenge (2018) (0)
- Production of potent fully human polyclonal antibodies against Zaire Ebola virus in transchromosomal cattle (2015) (0)
- Transforming proteins of DNA tumor viruses (1989) (0)
- Stable incorporation of functionally active purified GPI-anchored immunostimulatory molecules on H5 influenza VLP surfaces by protein transfer. (113.33) (2012) (0)
- Novel influenza vaccines and transcutaneous vaccine delivery systems. (2008) (0)
- Double-stranded RNA viruses : proceedings of the first International symposium on Double-Stranded RNA viruses, held October 5-10, 1982, at Frenchman's Reef, St. Thomas, U.S. Virgin Islands (1983) (0)
- and Raft Association and Surface Expression Virus Envelope Protein Is Critical for Lipid Palmitoylation of the Murine Leukemia (1996) (0)
- Research letterGene products of influenza C virus (1980) (0)
- Enhanced immunogenicity of SIV Gag DNA vaccines encoding chimeric proteins containing a C-terminal segment of Listeriolysin O. (2003) (0)
- Skin immunization by microneedle patch overcomes statin-induced suppression of immune responses to influenza vaccine (2017) (0)
- Oligomerization, Transport, andGolgi Retention ofPuntaToro VirusGlycoproteins (1991) (0)
- Acknowledgment to reviewers (2018) (0)
- ThePGeneofHumanParainfluenza VirusType1 Encodes PandC Proteins butNota Cysteine- RichV Protein (1991) (0)
- DNA vaccination against influenza using a coated microneedle patch (2012) (0)
- Protein Traffic in Eukaryotic Cells: Selected Reviews (2011) (0)
- Improved protection against avian influenza H5N1 virus by a single microneedle skin vaccination with virus-like particles. (2010) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Richard W. Compans?
Richard W. Compans is affiliated with the following schools:
